Ken Griffin Singular Genomics Systems, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$0.4 - $0.61 $4,800 - $7,320	12,000 Added 1000.0%	13,200 $6,000
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $2,310 - $4,059	-7,000 Reduced 85.37%	1,200 $0
Q3 2023 Nov 14, 2023	SELL	$0.37 - $0.99 $1,591 - $4,257	-4,300 Reduced 34.4%	8,200 $3,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $546 - $896	700 Added 5.93%	12,500 $10,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.95 $7,370 - $19,765	6,700 Added 131.37%	11,800 $14,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $9,282 - $13,821	5,100 New	5,100 $10,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.56B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.